3 CORNERSTONE DRIVE STE 703 LANGHORNE, PA 19047

New Treatment for Patients With Recurrent Nasal Polyps.

If you’re suffering from nasal polyps, you are not alone.

Studies, including a survey by the National Center for Health Statistics, have shown that up to 10% of all Americans suffer from chronic sinusitis, with or without nasal polyps.
Symptoms of this condition include nasal discharge, loss of smell, facial pain, and persistent nasal obstruction, which can make it difficult to breathe. Symptoms are often treated with intranasal steroid sprays, saline rinses, and oral steroids.
To help address significant cases of chronic sinusitis, more than 500,000 endoscopic sinus surgeries (ESS) are performed in the United States annually.

What is SINUVA™?

The SINUVA Sinus Implant is an innovative technology that reduces polyps and the sensation of nasal congestion and obstruction with a 2-in-1 approach:

1. Designed to open in the sinus cavity
2. Delivers anti-inflammatory medicine to treat nasal polyps

  • SINUVA is delivered into the sinus cavity through the nasal opening during a routine office visit
  • A doctor will use topical and/or local anesthesia to numb your nose and sinuses
  • SINUVA usually cannot be felt once it’s in place
  • SINUVA can be removed at 90 days or earlier at your doctor’s discretion
DQxL4ncVwAMI8Fr

What is SINUVA™?

Because SINUVA is placed directly amongst the nasal polyps, it’s able to provide sustained symptom relief with a low rate of side effects.

As with all endoscopic sinus procedures, there are risks associated with the insertion and removal of the SINUVA Sinus Implant.

  • The risks from SINUVA are similar to those associated with other endoscopic sinus procedures, such as nose bleed, injuries to blood vessels, and bacterial infection.
    • SINUVA has not been studied in people with cystic fibrosis, acute bacterial infections, or invasive fungal sinusitis
    • SINUVA is not for people with hypersensitivity to corticosteroids or those with nasal ulcers or trauma